Skip to content
Back to Investors
1C

11.2 Capital

Venture Capital

11.2 Capital invests in founders addressing global challenges, focusing on emerging technologies in data-driven healthcare, AI, and infrastructure software.

Portfolio

1

companies

By category

  • MedTech£13.5M

By location

  • London£13.5M

Portfolio companies

uMed

uMed

uMed provides a technology platform that connects healthcare providers with clinical studies.


Recent investments

Series A
£9.8M

The financing was backed by Delin Ventures, AlbionVC, Playfair Capital and 11.2 Capital to support international growth and research programmes.

"We developed the uMed platform to help healthcare professionals more easily and efficiently run patient research and targeted care programmes at scale, improving outcomes for patients by mitigating care gaps and accelerating research. Our groundbreaking patient cohorts give researchers access to unique data and insights, accelerating development and access to new therapies, while dramatically reducing the cost of finding, engaging and collecting prospective data from patients."
— Matt Wilson, Founder and CEO
Seed
£3.7M

The seed follow-on round was backed by a consortium including AlbionVC, Delin Ventures, and Playfair Capital.

"Our technology can support healthcare providers in finding appropriate patients to participate in medical research including large scale patient registries which usually demands laborious, manual processes on top of their already complex and heavy workloads."
— Matt Wilson, Founder and CEO